Skip to content

Sutureless Muocardine Pacing Leads 471

by Intermedics, Inc. 510(k)

Active United States

510(k) K781570

Regulatory status

as of 29 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK781570 Date1 Feb 1979ClearedStatusActive

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Sutureless Myocardial Pacing Leads 471 are classified as Permanent Pacemaker Electrodes, designed to deliver electrical pacing impulses to the myocardium. These leads attach directly to heart tissue without requiring sutures, facilitating cardiac pacing for patients with bradycardia or related indications.

Implanted via a minimally invasive procedure, these leads are intended for use with permanent pacemaker systems. Supplied sterile and intended for single-use, they are regulated under FDA 510(k) clearance (K781570) and fall under the classification of Class III medical devices (DTB). Storage and handling must adhere to sterile medical device protocols.

Other devices from Intermedics, Inc.

See all devices from Intermedics, Inc. →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary purpose of the Sutureless Myocardial Pacing Leads 471, and how does their design differ from traditional pacing leads?

    The Sutureless Myocardial Pacing Leads 471 are designed to deliver electrical pacing impulses directly to the myocardium (heart muscle) for patients with bradycardia or related conditions. Unlike traditional pacing leads that require sutures for secure attachment, these leads are engineered to attach directly to heart tissue without the need for stitching, simplifying the implantation process during minimally invasive procedures.

  • Are these leads intended for single-use or can they be reused after implantation?

    These leads are explicitly supplied sterile and intended for single-use only. Reuse is not recommended or supported by the manufacturer, as it could compromise sterility and patient safety. Proper sterile handling and disposal protocols must be followed to maintain compliance with medical device regulations.

  • What storage conditions should be followed for the Sutureless Myocardial Pacing Leads 471 to ensure sterility and functionality?

    Since these leads are sterile upon packaging, they must be stored in accordance with standard sterile medical device protocols. This includes keeping them in their original, unopened packaging, away from direct sunlight or extreme temperatures, and protecting them from physical damage. Always verify the expiration date and integrity of the packaging before use.

  • What regulatory pathway was followed for FDA clearance of these leads, and which advisory committee was involved?

    The Sutureless Myocardial Pacing Leads 471 were cleared through the FDA 510(k) pathway under the classification of Class III medical devices (DTB). The submission was reviewed by the Cardiovascular (CV) Advisory Committee, and the decision was based on a determination of substantial equivalence (SESE) to a predicate device. The clearance number is K781570, filed in 1978.